Virtus LifeSci Biotech Products ETF (BBP)

Assets	$23.74M
Expense Ratio	0.79%
PE Ratio	n/a
Shares Out	400,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+0.77%

Volume	1,822
Open	58.80
Previous Close	58.62
Day's Range	58.72 - 59.07
52-Week Low	48.65
52-Week High	69.12
Beta	0.53
Holdings	57
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

20.07% of assets

Name	Symbol	Weight
BridgeBio Pharma, Inc.	BBIO	2.15%
CRISPR Therapeutics AG	CRSP	2.13%
Ionis Pharmaceuticals, Inc.	IONS	2.11%
Insmed Incorporated	INSM	1.98%
Aurinia Pharmaceuticals Inc.	AUPH	1.98%
Alnylam Pharmaceuticals, Inc.	ALNY	1.97%
Mirum Pharmaceuticals, Inc.	MIRM	1.95%
Exelixis, Inc.	EXEL	1.95%
Kiniksa Pharmaceuticals International, plc	KNSA	1.94%
Incyte Corporation	INCY	1.93%